TG Therapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 4 published signal records.
TG Therapeutics last closed at $53.34 (+0.74%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 19.0×. Its overall grade ranks 276 of 738 stocks in Healthcare.
About this company
TG Therapeutics last closed at $53.34 (+0.74%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 276/738
Valuation grade F
Related stocks
- RocheCompetitor
B세포질환·다발성경화증 등에서 TG Therapeutics와 치료제 경쟁
- NovartisCompetitor
MS 치료제 시장의 글로벌 경쟁사
- BiogenCompetitor
재발성 다발성경화증 등에서 직접 경쟁
ETFs holding this stock
Innovator IBD Breakout Opportunities ETF · Invesco S&P SmallCap Health Care ETF · Innovator IBD 50 ETF
Details →About TG Therapeutics
- What technical signals does TG Therapeutics (TGTX) have?
- TG Therapeutics current technical signals: no active technical signal.
- Is TG Therapeutics a cup-and-handle pattern?
- No. TG Therapeutics has no valid Cup signal right now.
- What published figures are available for TG Therapeutics?
- Market cap: $8.47B. Trailing 12 months PER: 19.0×. Latest quarter PBR: 13.89×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about TG Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.